STRS Ohio’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

STRS Ohio’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150	Closed	-$12K	–	2339
2022 Q1	$12K	Hold	150	–	–	﹤0.01%	2082
2021 Q4	$30K	Hold	150	–	–	﹤0.01%	2071
2021 Q3	$48K	Buy	150 +95	+173%	+$27.7K	﹤0.01%	2079
2021 Q2	$14K	Buy	+55	New	+$16.8K	﹤0.01%	2191

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

STRS Ohio's VINC Position: Q2 2022 in Review

STRS Ohio sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2022, closing a stake of 150 shares — an estimated $12K sold.

STRS Ohio first reported a position in VINC in Q2 2021 and held it in 4 quarters. The position peaked at $48K in Q3 2021. 51 funds tracked by Wall St. Rank hold VINC as of Q2 2022.

STRS Ohio reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 150 Vincerx Pharma, Inc. Common Stock shares in Q2 2022, an estimated $12K.
STRS Ohio first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
STRS Ohio's Vincerx Pharma, Inc. Common Stock position peaked at $48K in Q3 2021.
51 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.